Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pradip De

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Biomedicines|May 27, 2023
A CAF-Based Two-Cell Hybrid Co-Culture Model to Test Drug Resistance in Endometrial CancersRaed Sulaiman, Pradip De, Jennifer C Aske, et al.
International Journal of Molecular Sciences|March 28, 2024
Atlas of Tumor and Tumor Microenvironment Cells of Lymphovascular Space Invasion (LVSI) in High-Grade Serous Endometrial Adenocarcinoma: A Case StudyRaed Sulaiman, Adam Dale, Xiaoqian Lin, et al.
American Journal of Cancer Research|July 15, 2024
<i>Ex vivo</i> platform <i>en route</i> to functional precision medicine: clinical relevance in gynecological cancersRaed Sulaiman, Jennifer C Aske, Luis Rojas Espaillat, et al.
International Journal of Molecular Sciences|April 13, 2023
Characterization and Clinical Relevance of Endometrial CAFs: Correlation between Post-Surgery Event and Resistance to DrugsRaed Sulaiman, Pradip De, Jennifer C Aske, et al.
BMC Cancer|November 27, 2009
PHA665752, a small-molecule inhibitor of c-Met, inhibits hepatocyte growth factor-stimulated migration and proliferation of c-Met-positive neuroblastoma cellsHal E Crosswell, Anindya Dasgupta, Carlos S Alvarado, et al.
Experimental Cell Research|January 6, 2009
Expression of RAC2 in endothelial cells is required for the postnatal neovascular responsePradip De, Qiong Peng, Dmitry O Traktuev, et al.
International Journal of Molecular Sciences|June 8, 2017
Down's Syndrome and Triple Negative Breast Cancer: A Rare Occurrence of Distinctive Clinical RelationshipNandini Dey, Amy Krie, Jessica Klein, et al.
American Journal of Cancer Research|March 8, 2024
A landscape of patient-derived cancer-associated fibroblast signals in endometrial cancersRaed Sulaiman, Nischal Koirala, Jennifer C Aske, et al.
Biomedicines|January 21, 2023
Patient-Derived Primary Cancer-Associated Fibroblasts Mediate Resistance to Anti-Angiogenic Drug in Ovarian CancersRaed Sulaiman, Pradip De, Jennifer C Aske, et al.
Meta Gene|May 26, 2015
Enriched transcription factor signatures in triple negative breast cancer indicates possible targeted therapies with existing drugsScooter Willis, Pradip De, Nandini Dey, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Biomedicines|May 27, 2023
A CAF-Based Two-Cell Hybrid Co-Culture Model to Test Drug Resistance in Endometrial CancersRaed Sulaiman, Pradip De, Jennifer C Aske, et al.
International Journal of Molecular Sciences|March 28, 2024
Atlas of Tumor and Tumor Microenvironment Cells of Lymphovascular Space Invasion (LVSI) in High-Grade Serous Endometrial Adenocarcinoma: A Case StudyRaed Sulaiman, Adam Dale, Xiaoqian Lin, et al.
American Journal of Cancer Research|July 15, 2024
<i>Ex vivo</i> platform <i>en route</i> to functional precision medicine: clinical relevance in gynecological cancersRaed Sulaiman, Jennifer C Aske, Luis Rojas Espaillat, et al.
International Journal of Molecular Sciences|April 13, 2023
Characterization and Clinical Relevance of Endometrial CAFs: Correlation between Post-Surgery Event and Resistance to DrugsRaed Sulaiman, Pradip De, Jennifer C Aske, et al.
BMC Cancer|November 27, 2009
PHA665752, a small-molecule inhibitor of c-Met, inhibits hepatocyte growth factor-stimulated migration and proliferation of c-Met-positive neuroblastoma cellsHal E Crosswell, Anindya Dasgupta, Carlos S Alvarado, et al.
Experimental Cell Research|January 6, 2009
Expression of RAC2 in endothelial cells is required for the postnatal neovascular responsePradip De, Qiong Peng, Dmitry O Traktuev, et al.
International Journal of Molecular Sciences|June 8, 2017
Down's Syndrome and Triple Negative Breast Cancer: A Rare Occurrence of Distinctive Clinical RelationshipNandini Dey, Amy Krie, Jessica Klein, et al.
American Journal of Cancer Research|March 8, 2024
A landscape of patient-derived cancer-associated fibroblast signals in endometrial cancersRaed Sulaiman, Nischal Koirala, Jennifer C Aske, et al.
Biomedicines|January 21, 2023
Patient-Derived Primary Cancer-Associated Fibroblasts Mediate Resistance to Anti-Angiogenic Drug in Ovarian CancersRaed Sulaiman, Pradip De, Jennifer C Aske, et al.
Meta Gene|May 26, 2015
Enriched transcription factor signatures in triple negative breast cancer indicates possible targeted therapies with existing drugsScooter Willis, Pradip De, Nandini Dey, et al.
Pageof 7